-
1
-
-
36049000503
-
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
-
DOI 10.1002/cncr.23062
-
A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients Cancer 110 2007 2339 2346 (Pubitemid 350100757)
-
(2007)
Cancer
, vol.110
, Issue.10
, pp. 2339-2346
-
-
Khorana, A.A.1
Francis, C.W.2
Culakova, E.3
Kuderer, N.M.4
Lyman, G.H.5
-
2
-
-
61449137068
-
Overview of the postulated mechanisms linking cancer and thrombosis
-
H. ten Cate, and A. Falanga Overview of the postulated mechanisms linking cancer and thrombosis Pathophysiol Haemost Thromb 36 2008 122 130
-
(2008)
Pathophysiol Haemost Thromb
, vol.36
, pp. 122-130
-
-
Ten Cate, H.1
Falanga, A.2
-
3
-
-
13244265094
-
Clotting mechanisms and cancer: Implications in thrombus formation and tumor progression
-
A. Falanga, M. Marchetti, A. Vignoli, and D. Balducci Clotting mechanisms and cancer: implications in thrombus formation and tumor progression Clin Adv Hematol Oncol 1 2003 673 678
-
(2003)
Clin Adv Hematol Oncol
, vol.1
, pp. 673-678
-
-
Falanga, A.1
Marchetti, M.2
Vignoli, A.3
Balducci, D.4
-
4
-
-
0038718518
-
Venous thromboembolism and cancer: Risks and outcomes
-
A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 2003 I17 I21
-
(2003)
Circulation
, vol.107
-
-
Lee, A.Y.1
Levine, M.N.2
-
5
-
-
0343238850
-
Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study
-
J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 2000 809 815 (Pubitemid 30165241)
-
(2000)
Archives of Internal Medicine
, vol.160
, Issue.6
, pp. 809-815
-
-
Heit, J.A.1
Silverstein, M.D.2
Mohr, D.N.3
Petterson, T.M.4
O'Fallon, W.M.5
Melton III, L.J.6
-
6
-
-
2342514219
-
Risk Factors for Venous Thromboembolism in Hospitalized Patients with Acute Medical Illness: Analysis of the MEDENOX Study
-
DOI 10.1001/archinte.164.9.963
-
R. Alikhan, A.T. Cohen, S. Combe, M.M. Samama, L. Desjardins, and A. Eldor Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study Arch Intern Med 164 2004 963 968 (Pubitemid 38581515)
-
(2004)
Archives of Internal Medicine
, vol.164
, Issue.9
, pp. 963-968
-
-
Alikhan, R.1
Cohen, A.T.2
Combe, S.3
Samama, M.M.4
Desjardins, L.5
Eldor, A.6
Janbon, C.7
Leizorovicz, A.8
Olsson, C.-G.9
Turpie, A.G.G.10
-
7
-
-
0037054040
-
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: A population-based study
-
J.A. Heit, W.M. O'Fallon, T.M. Petterson, C.M. Lohse, M.D. Silverstein, and D.N. Mohr Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study Arch Intern Med 162 2002 1245 1248 (Pubitemid 34595030)
-
(2002)
Archives of Internal Medicine
, vol.162
, Issue.11
, pp. 1245-1248
-
-
Heit, J.A.1
Michael O'Fallon, W.2
Petterson, T.M.3
Lohse, C.M.4
Silverstein, M.D.5
Mohr, D.N.6
Joseph Melton III, L.7
-
8
-
-
34447641374
-
Venous thromboembolism in the outpatient setting
-
DOI 10.1001/archinte.167.14.1471
-
F.A. Spencer, D. Lessard, C. Emery, G. Reed, and R.J. Goldberg Venous thromboembolism in the outpatient setting Arch Intern Med 167 2007 1471 1475 (Pubitemid 47124177)
-
(2007)
Archives of Internal Medicine
, vol.167
, Issue.14
, pp. 1471-1475
-
-
Spencer, F.A.1
Lessard, D.2
Emery, C.3
Reed, G.4
Goldberg, R.J.5
-
9
-
-
40849111771
-
Clinical characteristics and management of cancer-associated acute venous thromboembolism: Findings from the MASTER Registry
-
DOI 10.3324/haematol.11458
-
D. Imberti, G. Agnelli, W. Ageno, M. Moia, G. Palareti, and R. Pistelli Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry Haematologica 93 2008 273 278 (Pubitemid 351397716)
-
(2008)
Haematologica
, vol.93
, Issue.2
, pp. 273-278
-
-
Imberti, D.1
Agnelli, G.2
Ageno, W.3
Moia, M.4
Palareti, G.5
Pistelli, R.6
Rossi, R.7
Verso, M.8
-
10
-
-
33644837478
-
Thromboembolism in hospitalized neutropenic cancer patients
-
DOI 10.1200/JCO.2005.03.8877
-
A.A. Khorana, C.W. Francis, E. Culakova, R.I. Fisher, N.M. Kuderer, and G.H. Lyman Thromboembolism in hospitalized neutropenic cancer patients J Clin Oncol 24 2006 484 490 (Pubitemid 46630468)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.3
, pp. 484-490
-
-
Khorana, A.A.1
Francis, C.W.2
Culakova, E.3
Fisher, R.I.4
Kuderer, N.M.5
Lyman, G.H.6
-
11
-
-
0037111563
-
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
-
DOI 10.1182/blood-2002-01-0108
-
P. Prandoni, A.W. Lensing, A. Piccioli, E. Bernardi, P. Simioni, and B. Girolami Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Blood 100 2002 3484 3488 (Pubitemid 35303914)
-
(2002)
Blood
, vol.100
, Issue.10
, pp. 3484-3488
-
-
Prandoni, P.1
Lensing, A.W.A.2
Piccioli, A.3
Bernardi, E.4
Simioni, P.5
Girolami, B.6
Marchiori, A.7
Sabbion, P.8
Prins, M.H.9
Noventa, F.10
Girolami, A.11
-
12
-
-
34047199865
-
Epidemiology of venous thromboembolism in 9489 patients with malignant glioma
-
T.J. Semrad, R. O'Donnell, T. Wun, H. Chew, D. Harvey, and H. Zhou Epidemiology of venous thromboembolism in 9489 patients with malignant glioma J Neurosurg 106 2007 601 608 (Pubitemid 46536455)
-
(2007)
Journal of Neurosurgery
, vol.106
, Issue.4
, pp. 601-608
-
-
Semrad, T.J.1
O'Donnell, R.2
Wun, T.3
Chew, H.4
Harvey, D.5
Zhou, H.6
White, R.H.7
-
13
-
-
13444256137
-
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
-
DOI 10.1001/jama.293.6.715
-
J.W. Blom, C.J. Doggen, S. Osanto, and F.R. Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722 (Pubitemid 40216041)
-
(2005)
Journal of the American Medical Association
, vol.293
, Issue.6
, pp. 715-722
-
-
Blom, J.W.1
Doggen, C.J.M.2
Osanto, S.3
Rosendaal, F.R.4
-
14
-
-
0036213529
-
Venous thrombosis in patients with solid tumors: Determination of frequency and characteristics
-
S. Sallah, J.Y. Wan, and N.P. Nguyen Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 2002 575 579 (Pubitemid 34302943)
-
(2002)
Thrombosis and Haemostasis
, vol.87
, Issue.4
, pp. 575-579
-
-
Sallah, S.1
Wan, J.Y.2
Nguyen, N.P.3
-
15
-
-
30944433554
-
Incidence of venous thromboembolism in patients hospitalized with cancer
-
DOI 10.1016/j.amjmed.2005.06.058, PII S0002934305005644
-
P.D. Stein, A. Beemath, F.A. Meyers, E. Skaf, J. Sanchez, and R.E. Olson Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 2006 60 68 (Pubitemid 43117468)
-
(2006)
American Journal of Medicine
, vol.119
, Issue.1
, pp. 60-68
-
-
Stein, P.D.1
Beemath, A.2
Meyers, F.A.3
Skaf, E.4
Sanchez, J.5
Olson, R.E.6
-
16
-
-
33645996692
-
Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: Results of a record linkage study
-
J.W. Blom, J.P. Vanderschoot, M.J. Oostindier, S. Osanto, F.J. van der Meer, and F.R. Rosendaal Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study J Thromb Haemost 4 2006 529 535
-
(2006)
J Thromb Haemost
, vol.4
, pp. 529-535
-
-
Blom, J.W.1
Vanderschoot, J.P.2
Oostindier, M.J.3
Osanto, S.4
Van Der Meer, F.J.5
Rosendaal, F.R.6
-
17
-
-
0036278814
-
Variation in relative risk of venous thromboembolism in different cancers
-
P.A. Thodiyil, and A.K. Kakkar Variation in relative risk of venous thromboembolism in different cancers Thromb Haemost 87 2002 1076 1077 (Pubitemid 34624894)
-
(2002)
Thrombosis and Haemostasis
, vol.87
, Issue.6
, pp. 1076-1077
-
-
Thodiyil, P.A.1
Kakkar, A.K.2
-
18
-
-
33644597912
-
Incidence of venous thromboembolism and its effect on survival among patients with common cancers
-
H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
-
(2006)
Arch Intern Med
, vol.166
, pp. 458-464
-
-
Chew, H.K.1
Wun, T.2
Harvey, D.3
Zhou, H.4
White, R.H.5
-
19
-
-
33748787140
-
Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM)
-
DOI 10.1016/j.critrevonc.2006.05.001, PII S1040842806001041
-
M. Mandala, A. Falanga, A. Piccioli, P. Prandoni, E.M. Pogliani, and R. Labianca Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM) Crit Rev Oncol Hematol 59 2006 194 204 (Pubitemid 44403960)
-
(2006)
Critical Reviews in Oncology/Hematology
, vol.59
, Issue.3
, pp. 194-204
-
-
Mandala, M.1
Falanga, A.2
Piccioli, A.3
Prandoni, P.4
Pogliani, E.M.5
Labianca, R.6
Barni, S.7
-
20
-
-
30144440519
-
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project
-
DOI 10.1097/01.sla.0000193959.44677.48
-
G. Agnelli, G. Bolis, L. Capussotti, R.M. Scarpa, F. Tonelli, and E. Bonizzoni A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project Ann Surg 243 2006 89 95 (Pubitemid 43054059)
-
(2006)
Annals of Surgery
, vol.243
, Issue.1
, pp. 89-95
-
-
Agnelli, G.1
Bolis, G.2
Capussotti, L.3
Scarpa, R.M.4
Tonelli, F.5
Bonizzoni, E.6
Moia, M.7
Parazzini, F.8
Rossi, R.9
Sonaglia, F.10
Valarani, B.11
Bianchini, C.12
Gussoni, G.13
-
21
-
-
0023818427
-
The thombogenic effect of anticancer drug therapy in women with Stage II breast cancer
-
M.N. Levine, M. Gent, J. Hirsh, A. Arnold, M.D. Goodyear, and W. Hryniuk The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer N Engl J Med 318 1988 404 407 (Pubitemid 18044179)
-
(1988)
New England Journal of Medicine
, vol.318
, Issue.7
, pp. 404-407
-
-
Levine, M.N.1
Gent, M.2
Hirsch, J.3
Arnold, A.4
Goodyear, M.D.5
Hryniuk, W.6
De Pauw, S.7
-
22
-
-
0942265619
-
Symptomatic Venous Thromboembolism in Cancer Patients Treated with Chemotherapy: An Underestimated Phenomenon
-
DOI 10.1001/archinte.164.2.190
-
H.M. Otten, J. Mathijssen, H. ten Cate, M. Soesan, M. Inghels, and D.J. Richel Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon Arch Intern Med 164 2004 190 194 (Pubitemid 38140406)
-
(2004)
Archives of Internal Medicine
, vol.164
, Issue.2
, pp. 190-194
-
-
Otten, H.-M.M.B.1
Mathijssen, J.2
Ten Cate, H.3
Soesan, M.4
Inghels, M.5
Richel, D.J.6
Prins, M.H.7
-
23
-
-
29144486069
-
Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
-
DOI 10.1002/cncr.21496
-
A.A. Khorana, C.W. Francis, E. Culakova, and G.H. Lyman Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer 104 2005 2822 2829 (Pubitemid 41798294)
-
(2005)
Cancer
, vol.104
, Issue.12
, pp. 2822-2829
-
-
Khorana, A.A.1
Francis, C.W.2
Culakova, E.3
Lyman, G.H.4
-
24
-
-
33645749796
-
The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma
-
M. Mandala, A. Falanga, M. Cremonesi, M. Zaccanelli, I. Floriani, and M.G. Vigano The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma Thromb Haemost 95 2006 752 754
-
(2006)
Thromb Haemost
, vol.95
, pp. 752-754
-
-
Mandala, M.1
Falanga, A.2
Cremonesi, M.3
Zaccanelli, M.4
Floriani, I.5
Vigano, M.G.6
-
25
-
-
34248374711
-
The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma
-
DOI 10.1002/cncr.22626
-
E.D. Tetzlaff, A.M. Correa, J. Baker, J. Ensor, and J.A. Ajani The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma Cancer 109 2007 1989 1995 (Pubitemid 46744192)
-
(2007)
Cancer
, vol.109
, Issue.10
, pp. 1989-1995
-
-
Tetzlaff, E.D.1
Correa, A.M.2
Baker, J.3
Ensor, J.4
Ajani, J.A.5
-
27
-
-
0141973788
-
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients
-
DOI 10.1200/JCO.2003.08.008
-
M. Verso, and G. Agnelli Venous thromboembolism associated with long-term use of central venous catheters in cancer patients J Clin Oncol 21 2003 3665 3675 (Pubitemid 46594061)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.19
, pp. 3665-3675
-
-
Verso, M.1
Agnelli, G.2
-
28
-
-
1842556758
-
Thrombotic Complications of Central Venous Catheters in Cancer Patients
-
DOI 10.1634/theoncologist.9-2-207
-
D.J. Kuter Thrombotic complications of central venous catheters in cancer patients Oncologist 9 2004 207 216 (Pubitemid 38452120)
-
(2004)
Oncologist
, vol.9
, Issue.2
, pp. 207-216
-
-
Kuter, D.J.1
-
29
-
-
39049146634
-
Management of venous port systems in oncology: A review of current evidence
-
S. Vescia, A.K. Baumgartner, V.R. Jacobs, M. Kiechle-Bahat, A. Rody, and S. Loibl Management of venous port systems in oncology: a review of current evidence Ann Oncol 19 2008 9 15
-
(2008)
Ann Oncol
, vol.19
, pp. 9-15
-
-
Vescia, S.1
Baumgartner, A.K.2
Jacobs, V.R.3
Kiechle-Bahat, M.4
Rody, A.5
Loibl, S.6
-
30
-
-
52949107527
-
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology
-
L.D. Wagman, M.F. Baird, C.L. Bennett, P.L. Bockenstedt, S.R. Cataland, and J. Fanikos Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology J Natl Compr Canc Netw 6 2008 716 753
-
(2008)
J Natl Compr Canc Netw
, vol.6
, pp. 716-753
-
-
Wagman, L.D.1
Baird, M.F.2
Bennett, C.L.3
Bockenstedt, P.L.4
Cataland, S.R.5
Fanikos, J.6
-
31
-
-
23044444287
-
Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer
-
DOI 10.1200/JCO.2005.10.192
-
S. Couban, M. Goodyear, M. Burnell, S. Dolan, P. Wasi, and D. Barnes Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer J Clin Oncol 23 2005 4063 4069 (Pubitemid 46211311)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.18
, pp. 4063-4069
-
-
Couban, S.1
Goodyear, M.2
Burnell, M.3
Dolan, S.4
Wasi, P.5
Barnes, D.6
MacLeod, D.7
Burton, E.8
Andreou, P.9
Anderson, D.R.10
-
32
-
-
31544483971
-
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: Final results of a double-blind, placebo-controlled phase III trial
-
DOI 10.1093/annonc/mdj059
-
M. Karthaus, A. Kretzschmar, H. Kroning, M. Biakhov, D. Irwin, and N. Marschner Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial Ann Oncol 17 2006 289 296 (Pubitemid 43160120)
-
(2006)
Annals of Oncology
, vol.17
, Issue.2
, pp. 289-296
-
-
Karthaus, M.1
Kretzschmar, A.2
Kroning, H.3
Biakhov, M.4
Irwin, D.5
Marschner, N.6
Slabber, C.7
Fountzilas, G.8
Garin, A.9
Abecasis, N.G.F.10
Baronius, W.11
Steger, G.G.12
Sudhoff, T.13
Giorgetti, C.14
Reichardt, P.15
-
33
-
-
23044450305
-
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients
-
DOI 10.1200/JCO.2005.06.084
-
M. Verso, G. Agnelli, S. Bertoglio, F.C. Di Somma, F. Paoletti, and W. Ageno Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients J Clin Oncol 23 2005 4057 4062 (Pubitemid 46211310)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.18
, pp. 4057-4062
-
-
Verso, M.1
Agnelli, G.2
Bertoglio, S.3
Di Somma, F.C.4
Paoletti, F.5
Ageno, W.6
Bazzan, M.7
Parise, P.8
Quintavalla, R.9
Naglieri, E.10
Santoro, A.11
Imberti, D.12
Soraru, M.13
Mosca, S.14
-
34
-
-
46049090201
-
Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
-
DOI 10.1378/chest.08-0656
-
W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 381S 453S (Pubitemid 351894916)
-
(2008)
Chest
, vol.133
, Issue.SUPPL. 6
-
-
Geerts, W.H.1
Bergqvist, D.2
Pineo, G.F.3
Heit, J.A.4
Samama, C.M.5
Lassen, M.R.6
Colwell, C.W.7
-
35
-
-
38349068632
-
Clinical outcome of patients with upper-extremity deep vein thrombosis: Results from the RIETE Registry
-
F.J. Munoz, P. Mismetti, R. Poggio, R. Valle, M. Barron, and M. Guil Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry Chest 133 2008 143 148
-
(2008)
Chest
, vol.133
, pp. 143-148
-
-
Munoz, F.J.1
Mismetti, P.2
Poggio, R.3
Valle, R.4
Barron, M.5
Guil, M.6
-
36
-
-
35648954192
-
Adjuvant therapy and thrombosis: How to avoid the problem?
-
M.N. Levine Adjuvant therapy and thrombosis: how to avoid the problem? Breast 16 Suppl. 2 2007 S169 S174
-
(2007)
Breast
, vol.16
, Issue.SUPPL. 2
-
-
Levine, M.N.1
-
37
-
-
84868193838
-
Venous thromboembolism in hematologic malignancies
-
A.A. Khorana, C.W. Francis, Informa Healthcare New York %7 Ed.s Khorana A, Francis CW
-
A. Falanga, and M. Marchetti Venous thromboembolism in hematologic malignancies A.A. Khorana, C.W. Francis, Cancer-Associated Thrombosis: New Findings in Translational Science, Prevention, and Treatment 2007 Informa Healthcare New York 131 149 %7 Ed.s Khorana A, Francis CW.
-
(2007)
Cancer-Associated Thrombosis: New Findings in Translational Science, Prevention, and Treatment
, pp. 131-149
-
-
Falanga, A.1
Marchetti, M.2
-
38
-
-
34247568441
-
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy [10]
-
DOI 10.1111/j.1538-7836.2007.02374.x
-
A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 2007 632 634 (Pubitemid 46680709)
-
(2007)
Journal of Thrombosis and Haemostasis
, vol.5
, Issue.3
, pp. 632-634
-
-
Khorana, A.A.1
Francis, C.W.2
Culakova, E.3
Kuderer, N.M.4
Lyman, G.H.5
-
39
-
-
20444433198
-
In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: Modulation by lower-dose chemotherapy
-
DOI 10.1158/0008-5472.CAN-04-3156
-
L. Ma, G. Francia, A. Viloria-Petit, D.J. Hicklin, J. du Manoir, and J. Rak In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy Cancer Res 65 2005 5365 5373 (Pubitemid 40827350)
-
(2005)
Cancer Research
, vol.65
, Issue.12
, pp. 5365-5373
-
-
Ma, L.1
Francia, G.2
Viloria-Petit, A.3
Hicklin, D.J.4
Du Manoir, J.5
Rak, J.6
Kerbel, R.S.7
-
40
-
-
79953304684
-
The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal-based and cell-based models
-
L.L. Swystun, S. Mukherjee, M. Levine, and P.C. Liaw The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal-based and cell-based models J Thromb Haemost 9 2011 767 775
-
(2011)
J Thromb Haemost
, vol.9
, pp. 767-775
-
-
Swystun, L.L.1
Mukherjee, S.2
Levine, M.3
Liaw, P.C.4
-
41
-
-
63049125016
-
Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes
-
L.L. Swystun, L.Y. Shin, S. Beaudin, and P.C. Liaw Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes J Thromb Haemost 7 2009 619 626
-
(2009)
J Thromb Haemost
, vol.7
, pp. 619-626
-
-
Swystun, L.L.1
Shin, L.Y.2
Beaudin, S.3
Liaw, P.C.4
-
42
-
-
36348999748
-
Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity
-
DOI 10.1111/j.1538-7836.2007.02788.x
-
D. Lechner, M. Kollars, A. Gleiss, P.A. Kyrle, and A. Weltermann Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity J Thromb Haemost 5 2007 2445 2452 (Pubitemid 350154355)
-
(2007)
Journal of Thrombosis and Haemostasis
, vol.5
, Issue.12
, pp. 2445-2452
-
-
Lechner, D.1
Kollars, M.2
Gleiss, A.3
Kyrle, P.A.4
Weltermann, A.5
-
43
-
-
80055116732
-
Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity
-
[Electronic publication ahead of print]
-
J.C. Boles, J.C. Williams, R.M. Hollingsworth, J.G. Wang, S.L. Glover, and A.P. Owens III Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity Thromb Res 2011 July 13 [Electronic publication ahead of print]
-
(2011)
Thromb Res
-
-
Boles, J.C.1
Williams, J.C.2
Hollingsworth, R.M.3
Wang, J.G.4
Glover, S.L.5
Owens Iii, A.P.6
-
44
-
-
78649752778
-
Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release
-
Y. Fu, J. Zhou, H. Li, F. Cao, Y. Su, and S. Fan Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release Thromb Haemost 104 2010 1235 1241
-
(2010)
Thromb Haemost
, vol.104
, pp. 1235-1241
-
-
Fu, Y.1
Zhou, J.2
Li, H.3
Cao, F.4
Su, Y.5
Fan, S.6
-
45
-
-
41149154862
-
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: A study of the Arbeitsgemeinschaft Internistische Onkologie
-
S.E. Al-Batran, J.T. Hartmann, S. Probst, H. Schmalenberg, S. Hollerbach, and R. Hofheinz Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie J Clin Oncol 26 2008 1435 1442
-
(2008)
J Clin Oncol
, vol.26
, pp. 1435-1442
-
-
Al-Batran, S.E.1
Hartmann, J.T.2
Probst, S.3
Schmalenberg, H.4
Hollerbach, S.5
Hofheinz, R.6
-
46
-
-
80052751246
-
High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: A large retrospective analysis
-
R.A. Moore, N. Adel, E. Riedel, M. Bhutani, D.R. Feldman, and N.E. Tabbara High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis J Clin Oncol 29 2011 3466 3473
-
(2011)
J Clin Oncol
, vol.29
, pp. 3466-3473
-
-
Moore, R.A.1
Adel, N.2
Riedel, E.3
Bhutani, M.4
Feldman, D.R.5
Tabbara, N.E.6
-
48
-
-
77951575045
-
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia
-
P. Giordano, A.C. Molinari, G.C. Del Vecchio, P. Saracco, G. Russo, and M. Altomare Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia Am J Hematol 85 2010 325 330
-
(2010)
Am J Hematol
, vol.85
, pp. 325-330
-
-
Giordano, P.1
Molinari, A.C.2
Del Vecchio, G.C.3
Saracco, P.4
Russo, G.5
Altomare, M.6
-
49
-
-
0034111118
-
Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature
-
N.I. Weijl, M.F. Rutten, A.H. Zwinderman, H.J. Keizer, M.A. Nooy, and F.R. Rosendaal Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature J Clin Oncol 18 2000 2169 2178 (Pubitemid 30324370)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.10
, pp. 2169-2178
-
-
Weijl, N.I.1
Rutten, M.F.J.2
Zwinderman, A.H.3
Jan Keizer, H.4
Nooy, M.A.5
Rosendaal, F.R.6
Cleton, F.J.7
Osanto, S.8
-
50
-
-
3242773754
-
The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: A systematic review
-
DOI 10.1002/cncr.20347
-
S.R. Deitcher, and M.P. Gomes The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review Cancer 101 2004 439 449 (Pubitemid 38970595)
-
(2004)
Cancer
, vol.101
, Issue.3
, pp. 439-449
-
-
Deitcher, S.R.1
Gomes, M.P.V.2
-
51
-
-
0037219744
-
Effect of tamoxifen on venous thrombosis risk factors in women without cancer: The Breast Cancer Prevention Trial
-
DOI 10.1046/j.1365-2141.2003.03976.x
-
M. Cushman, J.P. Costantino, E.G. Bovill, D.L. Wickerham, L. Buckley, and J.D. Roberts Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial Br J Haematol 120 2003 109 116 (Pubitemid 36056917)
-
(2003)
British Journal of Haematology
, vol.120
, Issue.1
, pp. 109-116
-
-
Cushman, M.1
Costantino, J.P.2
Bovill, E.G.3
Wickerham, D.L.4
Buckley, L.5
Roberts, J.D.6
Krag, D.N.7
-
52
-
-
84857787311
-
Tamoxifen promotes superoxide production in platelets by activation of PI3-Kinase and NADPH oxidase pathways
-
[Electronic publication ahead of print]
-
V.P. Shah, H.A. Chegini, S.R. Vishneski, R.V. Weatherman, P.F. Blackmore, and Y. Dobrydneva Tamoxifen promotes superoxide production in platelets by activation of PI3-Kinase and NADPH oxidase pathways Thromb Res 2011 Aug 27 [Electronic publication ahead of print]
-
(2011)
Thromb Res
-
-
Shah, V.P.1
Chegini, H.A.2
Vishneski, S.R.3
Weatherman, R.V.4
Blackmore, P.F.5
Dobrydneva, Y.6
-
53
-
-
0029783365
-
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer
-
K.I. Pritchard, A.H. Paterson, N.A. Paul, B. Zee, S. Fine, and J. Pater Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group J Clin Oncol 14 1996 2731 2737 (Pubitemid 26329659)
-
(1996)
Journal of Clinical Oncology
, vol.14
, Issue.10
, pp. 2731-2737
-
-
Pritchard, K.I.1
Paterson, A.H.G.2
Paul, N.A.3
Zee, B.4
Fine, S.5
Pater, J.6
-
54
-
-
0024506261
-
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors
-
B. Fisher, J. Costantino, C. Redmond, R. Poisson, D. Bowman, and J. Couture A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors N Engl J Med 320 1989 479 484 (Pubitemid 19062522)
-
(1989)
New England Journal of Medicine
, vol.320
, Issue.8
, pp. 479-484
-
-
Fisher, B.1
Costantino, J.2
Redmond, C.3
Poisson, R.4
Bowman, D.5
Couture, J.6
Dimitrov, N.V.7
Wolmark, N.8
Wickerham, D.L.9
Fisher, E.R.10
Margolese, R.11
Robidoux, A.12
Shibata, H.13
Terz, J.14
Paterson, A.H.G.15
Feldman, M.I.16
Farrar, W.17
Evans, J.18
Lickley, H.L.19
-
55
-
-
0030693661
-
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor- positive breast cancer
-
B. Fisher, J. Dignam, N. Wolmark, A. DeCillis, B. Emir, and D.L. Wickerham Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer J Natl Cancer Inst 89 1997 1673 1682 (Pubitemid 27508191)
-
(1997)
Journal of the National Cancer Institute
, vol.89
, Issue.22
, pp. 1673-1682
-
-
Fisher, B.1
Dignam, J.2
Wolmark, N.3
DeCillis, A.4
Emir, B.5
Wickerham, D.L.6
Bryant, J.7
Dimitrov, N.V.8
Abramson, N.9
Atkins, J.N.10
Shibata, H.11
Deschenes, L.12
Margolese, R.G.13
-
56
-
-
0037157603
-
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial
-
DOI 10.1016/S0140-6736(02)09088-8
-
M. Baum, A.U. Budzar, J. Cuzick, J. Forbes, J.H. Houghton, and J.G. Klijn Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Lancet 359 2002 2131 2139 (Pubitemid 34694019)
-
(2002)
Lancet
, vol.359
, Issue.9324
, pp. 2131-2139
-
-
Baum, M.1
Buzdar, A.U.2
Cuzick, J.3
Forbes, J.4
Houghton, J.5
Klijn, J.G.M.6
Sahmoud, T.7
-
57
-
-
77952171390
-
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: A prospective trial
-
M. Mandala, S. Barni, M. Prins, R. Labianca, C. Tondini, and L. Russo Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial Ann Oncol 21 2010 871 876
-
(2010)
Ann Oncol
, vol.21
, pp. 871-876
-
-
Mandala, M.1
Barni, S.2
Prins, M.3
Labianca, R.4
Tondini, C.5
Russo, L.6
-
58
-
-
0028217482
-
Phase i and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma
-
J.L. Grem, N. McAtee, R.F. Murphy, J.M. Hamilton, F. Balis, and S. Steinberg Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma J Clin Oncol 12 1994 560 568
-
(1994)
J Clin Oncol
, vol.12
, pp. 560-568
-
-
Grem, J.L.1
McAtee, N.2
Murphy, R.F.3
Hamilton, J.M.4
Balis, F.5
Steinberg, S.6
-
59
-
-
0031418172
-
Incidence and risk of thromboembolism during treatment of high-grade gliomas: A prospective study
-
DOI 10.1016/S0959-8049(97)00167-6, PII S0959804997001676
-
A.A. Brandes, E. Scelzi, G. Salmistraro, M. Ermani, C. Carollo, and F. Berti Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study Eur J Cancer 33 1997 1592 1596 (Pubitemid 28123480)
-
(1997)
European Journal of Cancer
, vol.33
, Issue.10
, pp. 1592-1596
-
-
Brandes, A.A.1
Scelzi, E.2
Salmistraro, G.3
Ermani, M.4
Carollo, C.5
Berti, F.6
Zampieri, P.7
Baiocchi, C.8
Fiorentino, M.V.9
-
60
-
-
55549105814
-
Hemostatic complications of angiogenesis inhibitors in cancer patients
-
F. Elice, J. Jacoub, F.R. Rickles, A. Falanga, and F. Rodeghiero Hemostatic complications of angiogenesis inhibitors in cancer patients Am J Hematol 83 2008 862 870
-
(2008)
Am J Hematol
, vol.83
, pp. 862-870
-
-
Elice, F.1
Jacoub, J.2
Rickles, F.R.3
Falanga, A.4
Rodeghiero, F.5
-
61
-
-
0142029001
-
Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy
-
C.E. Behrendt, and R.B. Ruiz Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy Thromb Haemost 90 2003 734 737 (Pubitemid 37287643)
-
(2003)
Thrombosis and Haemostasis
, vol.90
, Issue.4
, pp. 734-737
-
-
Behrendt, C.E.1
Ruiz, R.B.2
-
62
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
DOI 10.1056/NEJMoa032691
-
H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, and W. Heim Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342 (Pubitemid 38702844)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.23
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
Heim, W.6
Berlin, J.7
Baron, A.8
Griffing, S.9
Holmgren, E.10
Ferrara, N.11
Fyfe, G.12
Rogers, B.13
Ross, R.14
Kabbinavar, F.15
-
63
-
-
34548141828
-
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
-
DOI 10.1093/jnci/djm086
-
F.A. Scappaticci, J.R. Skillings, S.N. Holden, H.P. Gerber, K. Miller, and F. Kabbinavar Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab J Natl Cancer Inst 99 2007 1232 1239 (Pubitemid 47299901)
-
(2007)
Journal of the National Cancer Institute
, vol.99
, Issue.16
, pp. 1232-1239
-
-
Scappaticci, F.A.1
Skillings, J.R.2
Holden, S.N.3
Gerber, H.-P.4
Miller, K.5
Kabbinavar, F.6
Bergsland, E.7
Ngai, J.8
Holmgren, E.9
Wang, J.10
Hurwitz, H.11
-
64
-
-
33745291997
-
Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations
-
DOI 10.1160/TH06-02-0080
-
M.A. Hussein Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations Thromb Haemost 95 2006 924 930 (Pubitemid 43933748)
-
(2006)
Thrombosis and Haemostasis
, vol.95
, Issue.6
, pp. 924-930
-
-
Hussein, M.A.1
-
65
-
-
0037103292
-
Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: Implications for therapy
-
DOI 10.1182/blood-2002-01-0335
-
M. Zangari, E. Siegel, B. Barlogie, E. Anaissie, F. Saghafifar, and A. Fassas Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy Blood 100 2002 1168 1171 (Pubitemid 34864267)
-
(2002)
Blood
, vol.100
, Issue.4
, pp. 1168-1171
-
-
Zangari, M.1
Siegel, E.2
Barlogie, B.3
Anaissie, E.4
Saghafifar, F.5
Fassas, A.6
Morris, C.7
Fink, L.8
Tricot, G.9
-
66
-
-
0038692110
-
Thalidomide and deep vein thrombosis in multiple myeloma: Risk factors and effect on survival
-
M. Zangari, B. Barlogie, R. Thertulien, J. Jacobson, P. Eddleman, and L. Fink Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival Clin Lymphoma 4 2003 32 35 (Pubitemid 36826874)
-
(2003)
Clinical Lymphoma
, vol.4
, Issue.1
, pp. 32-35
-
-
Zangari, M.1
Barlogie, B.2
Thertulien, R.3
Jacobson, J.4
Eddleman, P.5
Fink, L.6
Fassas, A.7
Van Rhee, F.8
Talamo, G.9
Lee, C.-K.10
Tricot, G.11
-
67
-
-
0141452131
-
Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin
-
DOI 10.1002/cncr.11700
-
T. Wun, L. Law, D. Harvey, B. Sieracki, S.A. Scudder, and J.K. Ryu Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin Cancer 98 2003 1514 1520 (Pubitemid 37151508)
-
(2003)
Cancer
, vol.98
, Issue.7
, pp. 1514-1520
-
-
Wun, T.1
Law, L.2
Harvey, D.3
Sieracki, B.4
Scudder, S.A.5
Ryu, J.K.6
-
68
-
-
40349103260
-
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
-
DOI 10.1001/jama.299.8.914
-
C.L. Bennett, S.M. Silver, B. Djulbegovic, A.T. Samaras, C.A. Blau, and K.J. Gleason Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia JAMA 299 2008 914 924 (Pubitemid 351397066)
-
(2008)
JAMA - Journal of the American Medical Association
, vol.299
, Issue.8
, pp. 914-924
-
-
Bennett, C.L.1
Silver, S.M.2
Djulbegovic, B.3
Samaras, A.T.4
Blau, C.A.5
Gleason, K.J.6
Barnato, S.E.7
Elverman, K.M.8
Courtney, D.M.9
McKoy, J.M.10
Edwards, B.J.11
Tigue, C.C.12
Raisch, D.W.13
Yarnold, P.R.14
Dorr, D.A.15
Kuzel, T.M.16
Tallman, M.S.17
Trifilio, S.M.18
West, D.P.19
Lai, S.Y.20
Henke, M.21
more..
-
69
-
-
43449115194
-
Development and validation of a predictive model for chemotherapy- associated thrombosis
-
A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 2008 4902 4907
-
(2008)
Blood
, vol.111
, pp. 4902-4907
-
-
Khorana, A.A.1
Kuderer, N.M.2
Culakova, E.3
Lyman, G.H.4
Francis, C.W.5
-
70
-
-
84857783741
-
A Predictive Risk Score for Cancer-Associated Thrombosis: Role of Screening in A Prospective Study
-
(ASH Annual Meeting Abstracts)
-
A.A. Khorana, K. Herman, D. Rubens, and C.W. Francis A Predictive Risk Score for Cancer-Associated Thrombosis: Role of Screening In A Prospective Study Blood Cells 116 2010 3173 (ASH Annual Meeting Abstracts).
-
(2010)
Blood Cells
, vol.116
, pp. 3173
-
-
Khorana, A.A.1
Herman, K.2
Rubens, D.3
Francis, C.W.4
-
71
-
-
53449093751
-
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: Results from the Vienna Cancer and Thrombosis Study (CATS)
-
C. Ay, R. Simanek, R. Vormittag, D. Dunkler, G. Alguel, and S. Koder High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) Blood 112 2008 2703 2708
-
(2008)
Blood
, vol.112
, pp. 2703-2708
-
-
Ay, C.1
Simanek, R.2
Vormittag, R.3
Dunkler, D.4
Alguel, G.5
Koder, S.6
-
72
-
-
70249119693
-
D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: Results from the Vienna Cancer and Thrombosis Study
-
C. Ay, R. Vormittag, D. Dunkler, R. Simanek, A.L. Chiriac, and J. Drach D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study J Clin Oncol 27 2009 4124 4129
-
(2009)
J Clin Oncol
, vol.27
, pp. 4124-4129
-
-
Ay, C.1
Vormittag, R.2
Dunkler, D.3
Simanek, R.4
Chiriac, A.L.5
Drach, J.6
-
73
-
-
78650055834
-
Prediction of venous thromboembolism in cancer patients
-
C. Ay, D. Dunkler, C. Marosi, A.L. Chiriac, R. Vormittag, and R. Simanek Prediction of venous thromboembolism in cancer patients Blood 116 2010 5377 5382
-
(2010)
Blood
, vol.116
, pp. 5377-5382
-
-
Ay, C.1
Dunkler, D.2
Marosi, C.3
Chiriac, A.L.4
Vormittag, R.5
Simanek, R.6
-
74
-
-
0033850037
-
Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: A retrospective analysis
-
B.A. Hutten, M.H. Prins, M. Gent, J. Ginsberg, J.G. Tijssen, and H.R. Buller Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis J Clin Oncol 18 2000 3078 3083
-
(2000)
J Clin Oncol
, vol.18
, pp. 3078-3083
-
-
Hutten, B.A.1
Prins, M.H.2
Gent, M.3
Ginsberg, J.4
Tijssen, J.G.5
Buller, H.R.6
-
75
-
-
0030751133
-
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group
-
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group Br J Surg 84 1997 1099 1103
-
(1997)
Br J Surg
, vol.84
, pp. 1099-1103
-
-
-
76
-
-
0037187892
-
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer
-
DOI 10.1056/NEJMoa012385
-
D. Bergqvist, G. Agnelli, A.T. Cohen, A. Eldor, P.E. Nilsson, and A. Le Moigne-Amrani Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer N Engl J Med 346 2002 975 980 (Pubitemid 34983247)
-
(2002)
New England Journal of Medicine
, vol.346
, Issue.13
, pp. 975-980
-
-
Bergqvist, D.1
Agnelli, G.2
Cohen, A.T.3
Eldor, A.4
Nilsson, P.E.5
Le Moigne-Amrani, A.6
Dietrich-Neto, F.7
-
77
-
-
70350714641
-
Venous thromboembolism prophylaxis and treatment in cancer: A consensus statement of major guidelines panels and call to action
-
A.A. Khorana, M.B. Streiff, D. Farge, M. Mandala, P. Debourdeau, and F. Cajfinger Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action J Clin Oncol 27 2009 4919 4926
-
(2009)
J Clin Oncol
, vol.27
, pp. 4919-4926
-
-
Khorana, A.A.1
Streiff, M.B.2
Farge, D.3
Mandala, M.4
Debourdeau, P.5
Cajfinger, F.6
-
78
-
-
0033539025
-
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
-
DOI 10.1056/NEJM199909093411103
-
M.M. Samama, A.T. Cohen, J.Y. Darmon, L. Desjardins, A. Eldor, and C. Janbon A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group N Engl J Med 341 1999 793 800 (Pubitemid 29420474)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.11
, pp. 793-800
-
-
Samama, M.M.1
Cohen, A.T.2
Darmon, J.-Y.3
Desjardins, L.4
Eldor, A.5
Janbon, C.6
Leizorovicz, A.7
Nguyen, H.8
Olsson, C.-G.9
Turpie, A.G.10
Weisslinger, N.11
-
79
-
-
68649111822
-
A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial
-
(abstract)
-
H. Riess, U. Pelzer, G. Deutschinoff, B. Opitz, M. Stauch, and P. Reitzig A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial J Clin Oncol 27 2009 LBA4506 (abstract).
-
(2009)
J Clin Oncol
, vol.27
, pp. 4506
-
-
Riess, H.1
Pelzer, U.2
Deutschinoff, G.3
Opitz, B.4
Stauch, M.5
Reitzig, P.6
-
80
-
-
58149377600
-
Rationale and design of PROSPECT-CONKO 004: A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)
-
H. Riess, U. Pelzer, A. Hilbig, J. Stieler, B. Opitz, and T. Scholten Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy) BMC Cancer 8 2008 361
-
(2008)
BMC Cancer
, vol.8
, pp. 361
-
-
Riess, H.1
Pelzer, U.2
Hilbig, A.3
Stieler, J.4
Opitz, B.5
Scholten, T.6
-
81
-
-
79955092671
-
Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): A multicentre, randomised phase IIB trial (the UK FRAGEM study)
-
A. Maraveyas, J. Waters, R. Roy, D. Propper, D. Fyfe, and F. Lofts Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study) Eur J Cancer Suppl 7 2009 362
-
(2009)
Eur J Cancer Suppl
, vol.7
, pp. 362
-
-
Maraveyas, A.1
Waters, J.2
Roy, R.3
Propper, D.4
Fyfe, D.5
Lofts, F.6
-
82
-
-
33749320687
-
Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer - Results of the TOPIC Studies
-
(abstract)
-
S.K. Haas, A.K. Kakkar, B. Kemkes-Matthes, M. Freund, U. Gatzemeier, and L. Heilmann Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer - Results of the TOPIC Studies J Thromb Haemost 3 2005 OR059 (abstract).
-
(2005)
J Thromb Haemost
, vol.3
, pp. 059
-
-
Haas, S.K.1
Kakkar, A.K.2
Kemkes-Matthes, B.3
Freund, M.4
Gatzemeier, U.5
Heilmann, L.6
-
83
-
-
77956471946
-
PRODIGE: A randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
-
J.R. Perry, J.A. Julian, N.J. Laperriere, W. Geerts, G. Agnelli, and L.R. Rogers PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma J Thromb Haemost 8 2010 1959 1965
-
(2010)
J Thromb Haemost
, vol.8
, pp. 1959-1965
-
-
Perry, J.R.1
Julian, J.A.2
Laperriere, N.J.3
Geerts, W.4
Agnelli, G.5
Rogers, L.R.6
-
84
-
-
70349398317
-
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: A randomised, placebo-controlled, double-blind study
-
G. Agnelli, G. Gussoni, C. Bianchini, M. Verso, M. Mandala, and L. Cavanna Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study Lancet Oncol 10 2009 943 949
-
(2009)
Lancet Oncol
, vol.10
, pp. 943-949
-
-
Agnelli, G.1
Gussoni, G.2
Bianchini, C.3
Verso, M.4
Mandala, M.5
Cavanna, L.6
-
85
-
-
33745909893
-
International Consensus Statement (guidelines according to scientific evidence)
-
Prevention and treatment of venous thromboembolism
-
Prevention and treatment of venous thromboembolism International Consensus Statement (guidelines according to scientific evidence) Int Angiol 25 2006 101 161
-
(2006)
Int Angiol
, vol.25
, pp. 101-161
-
-
-
86
-
-
77955507375
-
The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients
-
M.B. Streiff The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients Thromb Res 125 Suppl. 2 2010 S128 S133
-
(2010)
Thromb Res
, vol.125
, Issue.SUPPL. 2
-
-
Streiff, M.B.1
-
87
-
-
77953580551
-
2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group
-
D. Farge, L. Bosquet, D. Kassab-Chahmi, P. Mismetti, I. Elalamy, and G. Meyer 2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group Crit Rev Oncol Hematol 73 2010 31 46
-
(2010)
Crit Rev Oncol Hematol
, vol.73
, pp. 31-46
-
-
Farge, D.1
Bosquet, L.2
Kassab-Chahmi, D.3
Mismetti, P.4
Elalamy, I.5
Meyer, G.6
-
88
-
-
77954325044
-
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management
-
M. Mandala, A. Falanga, and F. Roila Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management Ann Oncol 21 Suppl. 5 2010 v274 v276
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 5
-
-
Mandala, M.1
Falanga, A.2
Roila, F.3
-
89
-
-
77955496152
-
Prevention and treatment of venous thromboembolism among patients with cancer: The American Society of Clinical Oncology Guidelines
-
G.H. Lyman, and N.M. Kuderer Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines Thromb Res 125 Suppl. 2 2010 S120 S127
-
(2010)
Thromb Res
, vol.125
, Issue.SUPPL. 2
-
-
Lyman, G.H.1
Kuderer, N.M.2
|